CitrusLabs is offering its services for free to organisations and researchers trying to find vaccines and drugs to treat Covid-19. The company has helped with 200 clinical trials worldwide over the last five years.
Founders Susanne Mitschke, Patrick Renner and Roger Arellano started the firm after seeing the effects of illness such as cognitive decline on loved ones. Eighty-six per cent of clinical trials are held up by problems recruiting trial subjects.
“Conditions like CovidD-19 affect so many of us, not only the sufferers but family, friends and the support systems around those suffering, and we want to be part of the team who find a vaccine and treatment.”
The co-founders are graduates of the universities of Glasgow and Strathclyde. Their work has helped scientists researching treatments for Alzheimer’s disease, dementia and brain injury. CitrusLabs has raised $5 million from investors including 2048 Ventures, One Way Ventures, Mucker Capital and Launch Capital. Clients include Australian biotech firm Actinogen, University of Texas and the University of Washington.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!